Skip to content

Follow-Up after Revascularization using Laser Speckle Contrast Imaging & transcutaneous oxygen pressure - A multicenter Trial

Follow-Up after Revascularization using Laser Speckle Contrast Imaging & transcutaneous oxygen pressure - A multicenter Trial - FoRever

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON53252
Enrollment
152
Registered
2023-08-31
Start date
2024-03-13
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic limb threatening ischemia chronic oxygen deficiency in the leg vessels

Interventions

None listed

Sponsors

Ziekenhuisgroep Twente
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with ischemic foot ulcers >=18 years of age Planned to receive revascularization treatment by standard care practice protocol. Willing to give written informed consent and willing and able to comply with the study protocol Fontaine 3 and 4

Exclusion criteria

Exclusion criteria: - Patients with contact restrictions. - Forefoot amputation or larger - Patients with large wounds or severe gangrene will be excluded when this would make applying the TcPO2 suction cups impossible.

Design outcomes

Primary

MeasureTime frame
LSCI (Perfusion Units) at specific regions or over time. Oxygen (TcPO2) pressure in mmHg per measurement location and over time Clinical outcome using multiple parameters derived from the patient files, such as wound healing (time to), successful revascularization (based on DSA), ankle brachial index, toe pressure, amputation yes/no, wound status (WiFi classification) and VAS score

Secondary

MeasureTime frame
Objective 1,2 and 3, are needed to answer the main objective and therefore use the same parameters. Objective 4 will use additional regions of interest (measured in Perfusion Units) to determine the distribution of LSCI perfusion units in the presence of an ulcer.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 14, 2026